Results 31 to 40 of about 14,183,490 (208)

Response rate.

open access: yes, 2020
Response rate.
André Bleich (2201215)   +5 more
core   +1 more source

KiGGS Wave 2 cross-sectional study – participant acquisition, response rates and representativeness [PDF]

open access: yesJournal of Health Monitoring, 2018
For the third time, wave 2 of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS), which is conducted in the context of health monitoring at the Robert Koch Institute, now provides representative cross-sectional data ...
Robert Hoffmann   +8 more
doaj   +1 more source

Immune Microenvironment and Response in Prostate Cancer Using Large Population Cohorts

open access: yesFrontiers in Immunology, 2021
Immune microenvironment of prostate cancer (PCa) is implicated in disease progression. However, previous studies have not fully explored PCa immune microenvironment.
Xiaohan Ren   +19 more
doaj   +1 more source

The effects of a negative contingency between response rate and reinforcement rate on rate of responding [PDF]

open access: yes, 1987
If the molar dependency between response rate and reinforcement rate can affect response rates, then responding should decrease when subjects are presented with a schedule which produces a negative contingency between response and reinforcement rates ...
Spear, Debra Jean   +1 more
core  

Response rate of patients with baseline brain metastases from recently diagnosed non‐small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status

open access: yesThoracic Cancer, 2020
Background Previous studies have identified that patients with EGFR mutations tend to have better responses to targeted therapy, as well as chemotherapy; however, the effect of genetic alterations in terms of radiotherapy (RT)‐related outcomes has not ...
Oscar Arrieta   +10 more
doaj   +1 more source

Effectiveness of immunosuppressant use for the treatment of immune checkpoint inhibitor-induced liver injury: A systematic review and meta-analysis

open access: yesFrontiers in Oncology, 2023
BackgroundImmune-mediated liver injury caused by checkpoint inhibitors (ILICI) is a challenging clinical management issue. Although immunosuppressants are widely used to manage ILICI, no large-scale studies have proved definitive evidence for the most ...
Kefan Chen   +5 more
doaj   +1 more source

Practice Makes the Difference: The Effect of Rate-Building and Rate-Controlled Practice on Retention [PDF]

open access: yes, 2006
Six home-schooled students and one adult participant each initially practiced to accuracy two decks of five previously unknown multiplication facts. The decks were yoked for practice and reinforcement. Once accurate performance was achieved, overpractice
McGregor, Susan Jennifer
core  

Establishment of a cohort for deep phenotyping of the immune response to influenza vaccination among elderly individuals recruited from the general population

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Elderly individuals have the highest burden of disease from influenza infection but also the lowest immune response to influenza vaccination. A better understanding of the host response to influenza vaccination in the elderly is therefore urgently needed.
Manas K. Akmatov   +18 more
doaj   +1 more source

Immune Response to Hepatitis B Virus Vaccine Among People Living With HIV: A Meta-Analysis

open access: yesFrontiers in Immunology, 2021
BackgroundThere is conflicting evidence about whether a double dose of the hepatitis B virus (HBV) vaccine induces better immunity than the standard-dose vaccine for people living with HIV (PLWH).
Yakun Tian   +7 more
doaj   +1 more source

Implementation of MyChart for recruitment at an academic medical center

open access: yesJournal of Clinical and Translational Science
Introduction: Recruitment of participants into research studies remains a major concern for investigators. Using clinical teams to identify potentially eligible patients can present a significant barrier.
Carrie Dykes   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy